With new groundbreaking technology, Anivive discovered a new way for treating Lymphoma in dogs. Rather than chemotherapy, they developed what owners from the past have only dreamt of; a treatment that is taken 100% orally at home.
LAVERDIA-CA1 is presented as an immediate release coated tablet in three dosage strengths, 2.5 mg, 10 mg and 50 mg. Each presentation is supplied 50-count in an HDPE bottle with a heat sealed, child-resistant cap and a desiccant included in each bottle. The bottles are individually packaged into cartons.
LAVERDIA-CA1 (verdinexor) is indicated for the treatment of lymphoma in dogs.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.